| This week's sponsor is Premier Research. | |  | Powerful Partners: The Growing Role of Patient Advocates
We salute patient advocates on the vital role they play on Rare Disease Day, and every day. Read our white paper on how these patient groups are changing clinical research. Premier Research. It's what we do. Best. |
Today's Rundown Featured Story | | | Friday, March 2, 2018 Machine learning veteran Daphne Koller is leaving less than two years after joining Calico as chief computing officer. |
|
|
Top Stories Friday, March 2, 2018 Ionis Pharmaceuticals has shared data from a phase 1/2 trial of its Roche-partnered treatment for Huntington’s disease. The small trial linked the two highest doses of antisense drug RG6042 to a 40% drop in levels of the mutant protein that drives the neurodegenerative disease. Friday, March 2, 2018 Shares in little Verona Pharma have jumped 20% on the back of data from a phase 2a cystic fibrosis trial. The limited look at data from a small, short trial contains tidbits of encouragement for Verona but ultimately paints an inconclusive picture of the prospects of PDE3/PDE4 inhibitor RPL554. Monday, February 26, 2018 Excellence is within reach. Learn how to earn distinction in today’s competitive healthcare marketplace by delivering the right drug to the right patient at the right time. Friday, March 2, 2018 Novartis has moved into the emerging digital therapeutics sector through a deal with the pioneering Pear Therapeutics. The agreement will see Novartis work with Pear to get a schizophrenia product to market while developing an earlier-stage treatment for multiple sclerosis. Thursday, March 1, 2018 Because glioblastomas are heterogeneous, some cancer cells evade treatment and continue to grow. Gianpietro Dotti of the University of North Carolina is targeting a CAR-T antigen that is "highly prevalent" on glioblastomas to tackle this heterogeneity. Thursday, March 1, 2018 In this week's EuroBiotech Report, AstraZeneca spinout raises $250 million, DBV climbs on milk allergy data, OBT raids Celgene and more. Friday, March 2, 2018 Shionogi’s Roche-partnered flu drug Xofluza won approval in Japan; Sun Pharma's key Halol plant was once again cited by the FDA; Chinese bispecific antibody developer EpimAb poached a top Novartis researcher for its CMO role; plus more pharma industry news from Asia. Friday, March 2, 2018 James Meyers is retiring as Gilead's commercial head, Amgen veteran Reshma Kewalramani was promoted to Vertex's CMO, Henrik Stenqvist jumped ship from Recipharm to Sobi as CFO, plus more hirings, firings and retirings throughout the industry. Resources Sponsored by: Reprints Desk The competitive landscape in medical device R&D is tough. And simply investing in R&D is no guarantee for profitability. So how do you accelerate time-to-market? Sponsored by: MK&A There’s no magic bullet to successful access but insights from patient advocates and industry experts can help shape future strategies. Learn how in this webinar. Sign up now! Presented by: Box and USDM Life Sciences Learn how biopharma and medical device companies can now collaborate on, manage and distribute regulated clinical, lab and manufacturing content in Box. That means all of your content is standardized on a single content repository that meets regulatory and compliance standards, so you can eliminate inefficient silos, enable seamless collaboration and accelerate the validation process. Sponsored by: RBC Wealth Management Employee stock option trading & administration, Restricted stock transactions (Rule 144), Affiliated trading plans (10b5-1), Directed share plans, Equity comp plan administration — private to public Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Presented by: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented by: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented by: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented by: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented by: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored by: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. | 
